Galena Biopharma Inc. (GALE) announced a deeply discounted $17 million public offering of common stock and warrants. Each unit for sale under the proposed offer consists of one full share of Galena Biopharma’s …
Galena
Galena Biopharma, Inc’s (GALE - Free Report) shares plunged 82.8% after the company announced that it has discontinued the phase III PRESENT study on its lead candidate, NeuVax (nelipepimut-S). The decision …
ZACKS9mon
Maxim Group have a $4.00 target on the stock. The target would suggest a potential upside of 150.00 % from …
NEW YORK, March 17, 2017 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, …
Deadline
The stock market crash of 1929 led to many bank failures and widespread ... the entire region of the central states and extended to the Atlantic …
Black Blizzards
Galena Biopharma Inc (NASDAQ:GALE)'s stock had its "outperform" rating reaffirmed by analysts at FBR & Co. in a note issued to investors on Saturday, AnalystRatings.NET reports. They presently have a $1.50 price …
Swiss pharma company Galenica Santé (SIX: GALE) raised CHF1.9 …
Europe
The U.S. Securities and Exchange Commission on Monday announced a crackdown on alleged stock promotion schemes in which writers ...
SEC